Dose-response effects of tropicamide HCl

Area of Science:

• Ophthalmology
• Pharmacology

Background:

• Tropicamide is a commonly used anticholinergic agent for ophthalmic examinations.
• Understanding the dose-response relationship of tropicamide is crucial for optimizing its clinical use.

Purpose of the Study:

• To evaluate the mydriatic and cycloplegic effects of varying tropicamide concentrations.
• To determine the optimal tropicamide concentration for mydriasis and cycloplegia in ophthalmic procedures.

Main Methods:

• Double-masking procedures were employed to assess tropicamide's effects.
• Four concentrations (0.25%, 0.5%, 0.75%, 1.0%) were tested under normal and bright illumination.
• Mydriasis and cycloplegic effects (amplitude of accommodation) were measured.

Main Results:

• All tested tropicamide concentrations produced clinically significant mydriasis (pupil size ≥ 6 mm).
• No significant differences in mydriatic effects were observed across concentrations or illumination levels.
• Cycloplegic effects were dose-dependent, with 0.75% and 1.0% tropicamide reducing accommodation amplitude to approximately 1.5 D.

Conclusions:

• Tropicamide effectively induces mydriasis at all tested concentrations.
• 0.75% and 1.0% tropicamide concentrations are sufficient for cycloplegic refractions.
• The choice of concentration can be tailored based on the required degree of cycloplegia.